The efficacy of other GLP-1RAs, including semaglutide and dual GLP-1/GIP agonist tirzepatide, in OA treatment is still under investigation
[DOI] [PMC free article] [PubMed] [Google Scholar] 46."With a little help from my friends" - the role of microbiota in thyroid hormone metabolism and enterohepatic recycling
[DOI] [PMC free article] [PubMed] [Google Scholar] 146.Brierley D.I., de Lartigue G
This analysis found that tirzepatide 10 mg and 15 mg provided greater long-term health benefits than semaglutide 2.0 mg by reducing risk factors such as HbA1c and body weight
Based on self-reported data from 111 Nexlife members, the average weight loss in the first six months is 29 lbs when combining GLP-1 injections with diet and exercise
Why it is important to treat obesity Medications for the treatment of obesity: Overview Metabolic side effects: Monitoring Monitoring for metabolic side effects in patients on a second-generation (atypical) antipsychotic Monitoring for metabolic side effects in children and adolescents on a second-generation (atypical) antipsychotic Metabolic side effects: Metformin Metformin to prevent or treat metabolic adverse effects due to antipsychotics Who is more likely to benefit from metformin for the management of metabolic adverse effects